Jeff Frelick, Chief Executive Officer at Bone Biologics Corp (BBLG), bought 7,600 shares at $0.66 ($5K) on 2023-08-31, disclosed to the SEC on 2023-09-05.
Open-market purchase of $5k BBLG by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Clearly above the average filing.